IHS Chemical Week

Regions :: North America :: U.S.

Bayer to divest interventional device business to Boston Scientific for $415 million

9:06 AM MDT | May 15, 2014 | Deepti Ramesh

Bayer HealthCare, a subgroup of Bayer, has entered into a definitive agreement to sell its interventional device business to medical devices company Boston Scientific (Natick, MA), for $415 million. Bayer’s interventional business, which is based near Minneapolis, generated sales of about $120 million in 2013 and employs about 350 people. The sale will include the AngioJet Ultra Thrombectomy System and the Jetstream Atherectomy System, as well as the Fetch2 Aspiration Catheter used in cardiology, radiology, and peripheral vascular procedures. The...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa